Accumulating evidence from cancer cell lines and animal models has demonstrated that SPOP mutations promote the initiation and progression of EC and PCa, potentially owing to the dysregulation of SPOP-mediated ubiquitination of its substrates [15, 18]. This evidence concerns the gene SPOP and posterior cortical atrophy.